SHIT2POWER secures funding

11.09.2024

We’re thrilled to announce that our alumni SHIT2POWER has secured a EUR 150k investment from the RAG-Stiftung via the BRYCK funding program. Alongside better ventures club & other exciting angels, we are participating in their successful past pre-seed round. 🚀

Former Exist scholarship holders Nina Heine & Fabian Habicht co-founded SHIT2POWER at Berlin’s Humboldt University in February 2023. Their mission: Turning wastewater treatment plants into power plants.

Why they joined BRYCK? Hear what Nina says:

„With its strong energy and industrial sector, the Ruhr region offers us great potential to bring our technology into scaleable use“

🏆 SHIT2POWER’s success story continues: The company has received several awards, including the ‚Gründungspreis+‘ from the Bundesministerium für Wirtschaft und Klimaschutz, the IDEE-Förderpreis from J.J. Darboven Holding AG & Co. KG, and won the contest to represent the Land Berlin at the Startup Germany Summit 2024 among 16 finalists from each federal state.

✅ They already reached this year’s major milestone and brought their first container plant live.

🙌 Congrats to this track-record, investment & progress! Keep up your important work for clean water & energy, Team SHIT2POWER! We are already looking forward to your upcoming SEED Round.

💡 We want more high-potential tech startups to emerge from universities just like SHIT2POWER. Therefore, we’ve joined forces with 3 universities to build an internationally recognized Startup Factory in the Ruhr area. Stay tuned for more updates coming soon!

Hier geht zum Post.

Diesen Artikel teilen

Gallerie

Ähnliche Themen

Simplyfined erhält Millionen-Förderung vom Bund

06.11.2024

1,7 Millionen Euro über zwei Jahre erhält das Gründerteam der TU Dortmund. Simplyfined arbeitet daran, Oleochemikalie...

Weiterlesen

Akribion Therapeutics GmbH sichert sich erste Seed-Finanzierungsrunde

05.11.2024

Akribion Therapeutics hat seine erste Seed-Finanzierungsrunde erfolgreich abgeschlossen und wird am 1. Dezember 2024 ...

Weiterlesen

BRAIN Biotech: Abspaltung von Akribion

01.11.2024

Akribion Therapeutics schließt einen exklusiven Lizenzvertrag mit der BRAIN Biotech AG für ihre CRISPR/Cas-Technologi...

Weiterlesen